Approval · Notice of Compliance 29559 · 2022
PMS-DIGOXIN: Notice of Compliance 29559
Issued November 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29559
- Date
- November 25, 2022
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-DIGOXIN | 02335700 | Marketed |
| PMS-DIGOXIN | 02335719 | Marketed |
| PMS-DIGOXIN | 02335727 | Dormant |
| PMS-DIGOXIN | 02242320 | Marketed |